{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T18:57:35Z","timestamp":1779217055464,"version":"3.51.4"},"reference-count":34,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["TCRM"],"DOI":"10.2147\/tcrm.s586907","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T13:50:14Z","timestamp":1776865814000},"page":"1-14","source":"Crossref","is-referenced-by-count":1,"title":["Camrelizumab Plus Apatinib in Advanced Unresectable Alveolar Soft Part Sarcoma and Undifferentiated Pleomorphic Sarcoma Patients: A Single-Center, Exploratory Case Series"],"prefix":"10.2147","volume":"Volume 22","author":[{"given":"Huijing","family":"Tan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2765-711X","authenticated-orcid":true,"given":"Huike","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianguo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liming","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5484-8950","authenticated-orcid":true,"given":"Susheng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenna","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yihebali","family":"Chi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2026,4]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"70","DOI":"10.32074\/1591-951X-213","volume":"113","author":"Sbaraglia","year":"2021","journal-title":"Pathologica"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1002\/1097-0142(195201)5:1<100::AID-CNCR2820050112>3.0.CO;2-K","volume":"5","author":"Christopherson","year":"1952","journal-title":"Cancer"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1038\/s41467-023-37049-z","volume":"14","author":"Tanaka","year":"2023","journal-title":"Nat Commun"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1001\/jamaoncol.2018.4490","volume":"5","author":"Paoluzzi","year":"2019","journal-title":"JAMA Oncol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.surg.2020.06.007","volume":"168","author":"Hagerty","year":"2020","journal-title":"Surgery"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"100775","DOI":"10.1016\/j.currproblcancer.2021.100775","volume":"45","author":"O\u2019Sullivan Coyne","year":"2021","journal-title":"Curr Probl Cancer"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.1111\/cas.14542","volume":"111","author":"Urakawa","year":"2020","journal-title":"Cancer Sci"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"50314","DOI":"10.18632\/oncotarget.18599","volume":"8","author":"Zhou","year":"2017","journal-title":"Oncotarget"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"e23521","DOI":"10.1200\/JCO.2018.36.15_suppl.e23521","volume":"36","author":"Min","year":"2018","journal-title":"J Clin Oncol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrclinonc.2018.29","volume":"15","author":"Fukumura","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"471","DOI":"10.3760\/cma.j.issn.0253-3766.2017.06.013","volume":"39","author":"Yang","year":"2017","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"ref12","unstructured":"Sarcoma Committee of Chinese Anti-Cancer Association, Chinese Society of Clinical Oncology. [Chinese expert consensus on diagnosis and treatment of soft tissue sarcomas (Version 2015)]. Zhonghua Zhong Liu Za Zhi. 2016;38(4):310\u2013320. Chinese. doi:10.3760\/cma.j.issn.0253-3766.2016.04.013"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"416\u2013421; discussion 412","DOI":"10.1097\/SLA.0000000000000869","volume":"260","author":"Brennan","year":"2014","journal-title":"Ann Surg"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s11912-011-0182-z","volume":"13","author":"Morgan","year":"2011","journal-title":"Curr Oncol Rep"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2217\/fon-2018-0074","volume":"14","author":"Blay","year":"2018","journal-title":"Future Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26642","volume":"64","author":"Rotz","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"3473","DOI":"10.1158\/1078-0432.CCR-22-0871","volume":"28","author":"Liu","year":"2022","journal-title":"Clin Cancer Res"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"102045","DOI":"10.1016\/j.esmoop.2023.102045","volume":"8","author":"Hindi","year":"2023","journal-title":"ESMO Open"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"11503","DOI":"10.1200\/JCO.2018.36.15_suppl.11503","volume":"36","author":"Chi","year":"2018","journal-title":"J Clin Oncol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1016\/S0140-6736(12)60651-5","volume":"379","author":"van der Graaf","year":"2012","journal-title":"Lancet"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1634\/theoncologist.2017-0161","volume":"23","author":"Stacchiotti","year":"2018","journal-title":"Oncologist"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"11015","DOI":"10.1200\/JCO.2019.37.15_suppl.11015","volume":"37","author":"Burgess","year":"2019","journal-title":"J Clin Oncol"},{"key":"ref23","unstructured":"Coyne G, Sharon E, Moore N, et al. Phase II study of atezolizumab in patients with alveolar soft part sarcoma. In: Connective Tissue Oncology Society Annual Meeting. 2018:3042818."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1056\/NEJMoa2303383","volume":"389","author":"Chen","year":"2023","journal-title":"N Engl J Med"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/S1470-2045(19)30153-6","volume":"20","author":"Wilky","year":"2019","journal-title":"Lancet Oncol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"5577","DOI":"10.1158\/1078-0432.CCR-24-2444","volume":"30","author":"Tan","year":"2024","journal-title":"Clin Cancer Res"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/S1470-2045(17)30334-0","volume":"18","author":"Gronchi","year":"2017","journal-title":"Lancet Oncol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.1200\/JCO.2008.20.4495","volume":"27","author":"Maki","year":"2009","journal-title":"J Clin Oncol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"5233","DOI":"10.1158\/1078-0432.CCR-17-3766","volume":"24","author":"Chi","year":"2018","journal-title":"Clin Cancer Res"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/S1470-2045(17)30624-1","volume":"18","author":"Tawbi","year":"2017","journal-title":"Lancet Oncol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/S1470-2045(18)30006-8","volume":"19","author":"D\u2019Angelo","year":"2018","journal-title":"Lancet Oncol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"6424","DOI":"10.1158\/1078-0432.CCR-21-2001","volume":"27","author":"Livingston","year":"2021","journal-title":"Clin Cancer Res"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1158\/1078-0432.CCR-23-2250","volume":"30","author":"Haddox","year":"2024","journal-title":"Clin Cancer Res"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"11505","DOI":"10.1200\/JCO.2024.42.16_suppl.11505","volume":"42","author":"Liu","year":"2024","journal-title":"J Clin Oncol"}],"container-title":["Therapeutics and Clinical Risk Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/article\/download\/114402","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/article\/download\/114402","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T13:50:18Z","timestamp":1776865818000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/camrelizumab-plus-apatinib-in-advanced-unresectable-alveolar-soft-part-peer-reviewed-fulltext-article-TCRM"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":34,"URL":"https:\/\/doi.org\/10.2147\/tcrm.s586907","relation":{},"ISSN":["1178-203X"],"issn-type":[{"value":"1178-203X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]}}}